Required sponsorship disclosures:
Current sponsors: Alkermes, Inc. (2016–present); Dr. Reddy’s Laboratories, Inc. (2023-present); Eisai Inc. (2022 – present); Johnson & Johnson/Janssen Pharmaceuticals, Inc (2019-present); Otsuka America Pharmaceutical, Inc. (2008–present); Sage Therapeutics (2019-present); Supernus Pharmaceuticals (2021-present); Teva Pharmaceutical Industries Ltd. (2018–present).
Previous sponsors: Forest/Actavis/Allergan (2016-2018, declined to sponsor: 2018-present); Aurobindo Pharma (2020-2022, declined to sponsor: 2022-present); AstraZeneca Pharmaceuticals (2009-2014, declined to sponsor: 2014-present); AuroMedics Pharma LLC (2021-2022, declined to sponsor: 2022-present); Ortho-McNeil-Janssen Pharmaceuticals, Inc (2009-2014, declined sponsorship: 2015-present); Pfizer, Inc. (2009-2011, declined sponsorship: 2012-present); Sunovion Pharmaceuticals, Inc. (2011-2023).
Declined to sponsor: AbbVie Inc.; Ajanta Pharma USA Inc.; Apotex Inc.; Arcolab Private Limited; Eli Lilly and Company; Intracellular Therapies, Inc.; Novartis Pharmaceuticals; Qilu Pharmaceutical Co., Ltd.; Vanda Pharmaceuticals Inc.
Financing information: Manufacturers of psychiatric medicines have been approached regarding the financing of the National Pregnancy Register. Regardless of which entities have supported this initiative, all drugs in this class are being studied. For more information on how you can sponsor the registry, please see the contact details below.
